Session: Advances and Case Studies in Crystallization and Post-Crystallization Processing (2010 Annual Meeting)

Description:

Papers are sought that describe novel approaches for carrying out crystallization or post-crystallization processing for desired product characteristics. The papers should use case studies and specific examples to illustrate the new methods.

Sponsor:

Crystallization and Evaporation

Co-Sponsor(s):

Solids Flow, Handling and Processing (03C)

Chair:

Seth Huggins
Senior Engineer
Amgen, Inc.
Process Engineering and Development
1 Amgen Center Drive
Thousand Oaks, CA 91320
Phone Number: 805-447-3710
Fax Number: 805-375-8753
Email: shuggins@amgen.com

Co-Chair:

Xing Wang
Novartis Pharmaceuticals Corporation
PDU4
USEH, 436-4221, One Health Plaza
East Hanover, NJ 07936-1080
Phone Number: 862-778-9457
Email: xing2.wang@novartis.com

Papers:

194a

Calcium Carbonate Crystallization Modulated by Anionic Polyelectrolytes
Mitali China, University at Buffalo, SUNY; Marina Tsianou, University at Buffalo - The State University of New York

194b

Controlled Crystallization of Nesquehonite by the Reaction of MgCl₂ with Na₂CO₃
Chen Yang, East China University of Science and Technology; Xingfu Song, East China University of Science and Technology; Jin Wang, East China University of Science and Technology; Shu-Yin Sun, East China University of Science and Technology; Jian-Guo Yu, East China University of Science and Technology

194c

Troubleshooting Micronization Performance for a Steroid Inhalation API – Conventional and Alternative Approaches
Plamen I. Grigorov, Merck and Co. Inc.; Dimitrios Zarkadas, Merck and Co. Inc.; Michael Whittington, Merck and Co. Inc.; Pericles Lagonikos, Merck and Co. Inc.

194d

Crystal Shape Engineering through Cycles of Dissolution and Growth
Matteo Muratore, University of Padua; Michael A. Lovette, University of California at Santa Barbara; Michael F. Doherty, University of California at Santa Barbara

194e

Crystallization and Phase Behavior: Polymorphism Case Study
Chiajen Lai, Bristol Myers Squibb; Qi Gao, Bristol Myers Squibb; Jun Huang, Bristol Myers Squibb; Alicia Ng, Bristol Myers Squibb; Deniz Erdemir, Bristol Myers Squibb

194f

Selection and Development of a De-Solvated Solid Form for An Active Pharmaceutical Ingredient
Bing-Shiou Yang, Boehringer Ingelheim Pharmaceuticals, Inc.; Zhibin Li, Boehringer Ingelheim Pharmaceuticals, Inc.; Ka Yip, Boehringer Ingelheim Pharmaceuticals, Inc.; Magnus Eriksson, Boehringer Ingelheim Pharmaceuticals, Inc.; Xingzhong Zeng, Boehringer Ingelheim Pharmaceuticals, Inc.; Soojin Kim, Boehringer Ingelheim Pharmaceuticals, Inc.; Nathan Yee, Boehringer Ingelheim Pharmaceuticals, Inc.; Chris Senanayake, Boehringer Ingelheim Pharmaceuticals, Inc.

194g

Practical API Spherical Crystallization Technology
Xing Wang, Novartis Pharmaceuticals Corporation

See more of this Group/Topical: Separations Division

<< Previous Session | Next Session >>